查看购物车
  • Traditional Chinese
  • English
  • Japanese
胎盘市场份额,规模,趋势,行业分析报告,按类型（猪,马,羊,其他）,按应用,按地区,按细分市场,预测，2023-2032 年
市场调查报告书
商品编码
1287675

胎盘市场份额,规模,趋势,行业分析报告,按类型（猪,马,羊,其他）,按应用,按地区,按细分市场,预测，2023-2032 年

Placenta Market Share, Size, Trends, Industry Analysis Report, By Type (Porcine, Equine, Ovine, Others); By Application; By Region; Segment Forecast, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris 市场研究的最新研究，到 2032 年，全球胎盘市场预计将达到 2.3601 亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场增长进行了分析。

推动胎盘市场的主要因素之一是对嫩肤和抗衰老产品的需求不断增长。 一个多世纪以来，利用胎盘中丰富的干细胞来帮助伤口护理和伤口癒合。 生长因子和抗炎蛋白的有效组合，尤其是在羊膜中，可以帮助身体在生病或受伤时与细胞相互作用。

胎盘细胞的正常功能可以在再生药物的帮助下恢復。 慢性疾病的有效治疗有望通过该领域的快速改进而实现。 例如，根据林一峰在2022年发表的研究论文，从人胎盘中产生的间充质干细胞是一种新的MSC替代来源，具有许多优点。 为了进一步了解其治疗功效和潜在的潜在机制，我们向 HP-MSC 注射了交联透明质酸水凝胶，以优化其在子宫内的保留。

市场扩张的主要驱动力之一是研发的高投资。 在预测期内，对减轻疾病负担的有效疗法的需求不断增长，也推动了增长。 例如，Felor Biniazan 于 2022 年进行的一项研究调查了基于胎盘的羊膜上皮细胞对小鼠损伤模型中伤口癒合过程和 TGF 诱导的疤痕形成的影响。

例如，Kirat Chand 于 2022 年发表的一项研究表明，hPD-MSC 疗法会导致代谢物和蛋白质水平以及衰老和年轻化的血清生物标誌物发生变化。 令人惊讶的是，hPD-MSC 疗法由于维生素 B6 代谢加快而增强了血清素合成。 重复输注治疗后肝臟血清素水平的增加改变了与肝细胞增殖和线粒体生物发生相关的 mRNA 和蛋白质的表达。 接受hPD-MSC治疗后血液代谢物的变化可以发现衰老和年轻化的生物标誌物。 血清素也是改善与年龄相关的肝臟衰退的重要治疗靶点。

胎盘市场报告亮点

  • 2022 年，Ovine 将主导整个市场并占据主要销售额。 对含有胎盘提取物的营养补充剂,药品和化妆品的需求不断增长是市场扩张的原因。
  • 2022 年，製药行业主导市场。 推动市场的关键因素是临床试验的增加,战略举措的增加,慢性病患病率的增加以及医疗保健服务的改善。
  • 2022 年，北美地区的销售额将最大。 推动市场的关键因素包括北美强大的生物技术行业,主要参与者的存在,广泛的研究和开发以及个性化医疗的推广。
  • 全球市场参与者包括 Brroklyn Placenta Services,Atlanta Placenta,MiMedx Group,TelaGen,Thimba Li 和 Agri-Labco-Products。

内容

第一章简介

第 2 章执行摘要

第三章研究方法

第 4 章全球胎盘市场洞察

  • 胎盘市场 - 行业概况
  • 胎盘市场动态
    • 驱动因素和机遇
      • 增加使用可再生能源进行能源生产
      • 燃料电池的需求不断增长
    • 制约因素和问题
      • 生产成本高
  • 杵分析
  • 胎盘行业的趋势
  • 价值链分析
  • COVID-19 的影响分析

第五章全球胎盘市场，按类型

  • 主要发现
  • 简介
  • 猪
  • 马
  • 羊
  • 其他

第 6 章全球胎盘市场，按应用划分

  • 主要发现
  • 简介
  • 药品
  • 化妆品
  • 补充剂
  • 其他

第 7 章：全球胎盘市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年胎盘市场评估（按地区）
  • 胎盘市场 - 北美
    • 北美：按应用划分的胎盘市场，2019-2032 年
    • 北美：按类型划分的胎盘市场，2019-2032 年
    • 胎盘市场 - 美国
    • 胎盘市场 - 加拿大
  • 胎盘市场 - 欧洲
    • 欧洲：按应用划分的胎盘市场，2019-2032 年
    • 欧洲：胎盘市场，按类型，2019-2032 年
    • 胎盘市场 - 英国
    • 胎盘市场 - 法国
    • 胎盘市场 - 德国
    • 胎盘市场 - 意大利
    • 胎盘市场 - 西班牙
    • 胎盘市场 - 荷兰
    • 胎盘市场 - 俄罗斯
  • 胎盘市场 - 亚太地区
    • 亚太地区：按应用划分的胎盘市场，2019-2032 年
    • 亚太地区：胎盘市场，按类型，2019-2032 年
    • 胎盘市场 - 中国
    • 胎盘市场 - 印度
    • 胎盘市场 - 马来西亚
    • 胎盘市场 - 日本
    • 胎盘市场 - 印度尼西亚
    • 胎盘市场 - 韩国
  • 胎盘市场 - 中东和非洲
    • 中东和非洲：按应用划分的胎盘市场，2019-2032 年
    • 中东和非洲：胎盘市场，按类型，2019-2032 年
    • 胎盘市场 - 沙特阿拉伯
    • 胎盘市场 - 阿拉伯联合酋长国
    • 胎盘市场 - 以色列
    • 胎盘市场 - 南非
  • 胎盘市场 - 拉丁美洲
    • 拉丁美洲：按应用划分的胎盘市场，2019-2032 年
    • 拉丁美洲：按类型划分的胎盘市场，2019-2032 年
    • 胎盘市场 - 墨西哥
    • 胎盘市场 - 巴西
    • 胎盘市场 - 阿根廷

第 8 章竞争格局

  • 扩张和收购分析
    • 扩展名
    • 收购
  • 伙伴关係/协作/协议/披露

第 9 章公司简介

  • Japan Natural Laboratories Co.Ltd
  • Japan Bio Products Co.Ltd
  • BIOON
  • CJT
  • Brroklyn Placenta Services
  • Atlanta Placenta
  • MiMedx Group, Inc
  • TelaGen
  • Thimba Li
  • Agri-Labco-Products
Product Code: PM3162

The global placenta market size is expected to reach USD 236.01 Million by 2032, according to a new study by Polaris market research. The report "Placenta Market Share, Size, Trends, Industry Analysis Report, By Type (Porcine, Equine, Ovine, Others); By Application; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

One of the main factors driving the placenta market is the increase in demand for skin-rejuvenating and anti-aging products. For more than a century, wound care and wound healing have been aided by the utilization of the abundant stem cells found in the placenta. A potent combination of growth factors and anti-inflammatory proteins, in particular, found in the amniotic membrane, can help the body interact with cells when it is ill or injured.

The normal function of placenta cells can be restored with the aid of regenerative drugs. Effective treatments for chronic illnesses are projected to be made possible by the field's quick improvements. For instance, mesenchymal stem cells generated from human placentas are a new alternative source of MSCs with a number of benefits, according to a research article by Yifeng Lin published in 2022. In order to further understand their therapeutic effectiveness and potential underlying mechanisms, we infused HP-MSCs with cross-linked hyaluronic acid hydrogel to optimize their retention inside the uterus.

One of the key drivers of market expansion is significant R&D investments. In addition, the growing need for potent treatments to lessen the burden of disease during the predicted period is another factor fueling the growth. For instance, a 2022 research study by Felor Biniazan examined the effects of the placenta based amniotic epithelial cells on wound healing process & TGF induced scar formation in a murine injury model.

For instance, according to a research study by Kirat Chand that was published in 2022, hPD-MSC therapy causes changes in metabolite and protein levels as well as serum biomarker(s) of ageing and/or rejuvenation. Surprisingly, hPD-MSC treatment boosted serotonin synthesis due to faster rates of vitamin B6 metabolism. The expression of mRNAs and proteins linked to hepatocyte proliferation and mitochondrial biogenesis was changed by elevated liver serotonin levels following repeated injection therapy. After receiving hPD-MSC therapy, metabolite changes in the blood can be used to find ageing and/or rejuvenation biomarkers. Serotonin is also an important therapeutic target for correcting liver deterioration brought on by ageing.

Placenta Market Report Highlights

  • In 2022, the Ovine dominated the whole market, accounting for major sales revenue. The rising demand for dietary supplements, medicines, and cosmetics that contain placenta extracts is to blame for the market's expansion.
  • The pharmaceutical industry dominated the market, in 2022. The significant factors driving the market are an increase in clinical trials, an increase in strategic initiatives, an increase in the prevalence of chronic diseases, and improvements in healthcare services.
  • North America hold the largest revenue in 2022. The main factors driving the market include North America's robust biotechnology sector, the existence of major players, considerable R&D, and the promotion of personalized medications.
  • The global players with global presence include Brroklyn Placenta Services, Atlanta Placenta, MiMedx Group, TelaGen, Thimba Li, and Agri-Labco-Products.

Polaris Market Research has segmented the Placenta Market report based on product type, application, and region:

Placenta, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Porcine
  • Equine
  • Ovine
  • Others

Placenta, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceuticals
  • Cosmetics
  • Supplements
  • Others

Placenta, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Placenta Market Insights

  • 4.1. Placenta Market - Industry Snapshot
  • 4.2. Placenta Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing use of renewable energy sources for energy production
      • 4.2.1.2. Rising fuel cell demand
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost production
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Placenta Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Placenta Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Placenta, by Type, 2019-2032 (USD Million)
  • 5.3. Porcine
    • 5.3.1. Global Placenta Market, by Porcine, by Region, 2019-2032 (USD Million)
  • 5.4. Equine
    • 5.4.1. Global Placenta Market, by Equine, by Region, 2019-2032 (USD Million)
  • 5.5. Ovine
    • 5.5.1. Global Placenta Market, by Ovine, by Region, 2019-2032 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Placenta Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Placenta Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Placenta Market, by Application, 2019-2032 (USD Million)
  • 6.3. Pharmaceuticals
    • 6.3.1. Global Placenta Market, by Pharmaceuticals, by Region, 2019-2032 (USD Million)
  • 6.4. Cosmetics
    • 6.4.1. Global Placenta Market, by Cosmetics, by Region, 2019-2032 (USD Million)
  • 6.5. Supplements
    • 6.5.1. Global Placenta Market, by Supplements, by Region, 2019-2032 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Placenta Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Placenta Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Placenta Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Placenta Market - North America
    • 7.3.1. North America: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.3.2. North America: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.3.3. Placenta Market - U.S.
      • 7.3.3.1. U.S.: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.3.4. Placenta Market - Canada
      • 7.3.4.1. Canada: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Placenta Market, by Type, 2019-2032 (USD Million)
  • 7.4. Placenta Market - Europe
    • 7.4.1. Europe: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.4.2. Europe: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.3. Placenta Market - UK
      • 7.4.3.1. UK: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.4. Placenta Market - France
      • 7.4.4.1. France: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.4.2. France: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.5. Placenta Market - Germany
      • 7.4.5.1. Germany: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.6. Placenta Market - Italy
      • 7.4.6.1. Italy: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.7. Placenta Market - Spain
      • 7.4.7.1. Spain: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.8. Placenta Market - Netherlands
      • 7.4.8.1. Netherlands: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.4.9. Placenta Market - Russia
      • 7.4.9.1. Russia: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Placenta Market, by Type, 2019-2032 (USD Million)
  • 7.5. Placenta Market - Asia Pacific
    • 7.5.1. Asia Pacific: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.3. Placenta Market - China
      • 7.5.3.1. China: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.3.2. China: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.4. Placenta Market - India
      • 7.5.4.1. India: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.4.2. India: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.5. Placenta Market - Malaysia
      • 7.5.5.1. Malaysia: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.6. Placenta Market - Japan
      • 7.5.6.1. Japan: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.7. Placenta Market - Indonesia
      • 7.5.7.1. Indonesia: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.5.8. Placenta Market - South Korea
      • 7.5.8.1. South Korea: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Placenta Market, by Type, 2019-2032 (USD Million)
  • 7.6. Placenta Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.6.3. Placenta Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.6.4. Placenta Market - UAE
      • 7.6.4.1. UAE: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.6.5. Placenta Market - Israel
      • 7.6.5.1. Israel: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.6.6. Placenta Market - South Africa
      • 7.6.6.1. South Africa: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Placenta Market, by Type, 2019-2032 (USD Million)
  • 7.7. Placenta Market - Latin America
    • 7.7.1. Latin America: Placenta Market, by Application, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.7.3. Placenta Market - Mexico
      • 7.7.3.1. Mexico: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.7.4. Placenta Market - Brazil
      • 7.7.4.1. Brazil: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Placenta Market, by Type, 2019-2032 (USD Million)
    • 7.7.5. Placenta Market - Argentina
      • 7.7.5.1. Argentina: Placenta Market, by Application, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Placenta Market, by Type, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Japan Natural Laboratories Co.Ltd
    • 9.1.1. Company Overview
    • 9.1.2. Financial PerTypeance
    • 9.1.3. Type Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Japan Bio Products Co.Ltd
    • 9.2.1. Company Overview
    • 9.2.2. Financial PerTypeance
    • 9.2.3. Type Benchmarking
    • 9.2.4. Recent Development
  • 9.3. BIOON
    • 9.3.1. Company Overview
    • 9.3.2. Financial PerTypeance
    • 9.3.3. Type Benchmarking
    • 9.3.4. Recent Development
  • 9.4. CJT
    • 9.4.1. Company Overview
    • 9.4.2. Financial PerTypeance
    • 9.4.3. Type Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Brroklyn Placenta Services
    • 9.5.1. Company Overview
    • 9.5.2. Financial PerTypeance
    • 9.5.3. Type Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Atlanta Placenta
    • 9.6.1. Company Overview
    • 9.6.2. Financial PerTypeance
    • 9.6.3. Type Benchmarking
    • 9.6.4. Recent Development
  • 9.7. MiMedx Group, Inc
    • 9.7.1. Company Overview
    • 9.7.2. Financial PerTypeance
    • 9.7.3. Type Benchmarking
    • 9.7.4. Recent Development
  • 9.8. TelaGen
    • 9.8.1. Company Overview
    • 9.8.2. Financial PerTypeance
    • 9.8.3. Type Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Thimba Li
    • 9.9.1. Company Overview
    • 9.9.2. Financial PerTypeance
    • 9.9.3. Type Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Agri-Labco-Products
    • 9.10.1. Company Overview
    • 9.10.2. Financial PerTypeance
    • 9.10.3. Type Benchmarking
    • 9.10.4. Recent Development

List of Tables

  • Table 1 Global Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 2 Global Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 3 Placenta Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 5 North America: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 6 U.S.: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 7 U.S.: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 8 Canada: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 9 Canada: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 10 Europe: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 11 Europe: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 12 UK: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 13 UK: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 14 France: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 15 France: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 16 Germany: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 17 Germany: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 18 Italy: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 19 Italy: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 20 Spain: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 21 Spain: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 22 Netherlands: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 23 Netherlands: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 24 Russia: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 25 Russia: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 28 China: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 29 China: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 30 India: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 31 India: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 32 Malaysia: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 33 Malaysia: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 34 Japan: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 35 Japan: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 36 Indonesia: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 37 Indonesia: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 38 South Korea: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 39 South Korea: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 44 UAE: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 45 UAE: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 46 Israel: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 47 Israel: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 48 South Africa: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 49 South Africa: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 50 Latin America: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 51 Latin America: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 52 Mexico: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 53 Mexico: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 54 Brazil: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 55 Brazil: Placenta Market, by Type, 2019-2032 (USD Million)
  • Table 56 Argentina: Placenta Market, by Application, 2019-2032 (USD Million)
  • Table 57 Argentina: Placenta Market, by Type, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Placenta Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Application
  • Figure 7 Global Placenta Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8 Market by Type
  • Figure 9 Global Placenta Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10 Placenta Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11 Strategic Analysis - Placenta Market